Ivanhoe Mines' reports Q3 2025 profit of $31M and adjusted EBITDA of $87M, including $76M of attributable EBITDA from ...
SELLAS Life Sciences Group, Inc. ( SLS) Discusses Innovation in AML Treatments With Focus on GPS and SLS009 Programs October 29, 2025 10:00 AM EDT ...
Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...
The software includes scattergrams comparing attempted vs achieved corrections, which can be used to refine surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback